MLN Matters Article (New) MM13073: National Coverage Determination: Cochlear Implantation
This new Article comprises Subregulatory Guidance for expanded coverage for cochlear implantation services performed as part of FDA-approved category B investigational device exemption clinical trials for patients not meeting the coverage criteria and as a routine cost in certain clinical trials for patients not meeting the coverage criteria. MLN Matters (MM) Articles are based on information contained within Change Requests (CRs). In this case, this article is based on content within CR13073 that is posted on the CMS website at https://www.cms.gov/files/document/r11875cp.pdf .
Final
Issued by: Centers for Medicare & Medicaid Services (CMS)
Issue Date: March 01, 2023
DISCLAIMER: The contents of this database lack the force and effect of law, except as authorized by law (including Medicare Advantage Rate Announcements and Advance Notices) or as specifically incorporated into a contract. The Department may not cite, use, or rely on any guidance that is not posted on the guidance repository, except to establish historical facts.